LT4621B - Nazalinis desmopresino įvedimas - Google Patents

Nazalinis desmopresino įvedimas Download PDF

Info

Publication number
LT4621B
LT4621B LT98-188A LT98188A LT4621B LT 4621 B LT4621 B LT 4621B LT 98188 A LT98188 A LT 98188A LT 4621 B LT4621 B LT 4621B
Authority
LT
Lithuania
Prior art keywords
desmopressin
solution
volume
composition
pharmaceutically acceptable
Prior art date
Application number
LT98-188A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT98188A (en
Inventor
Bengt Bengtsson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of LT98188A publication Critical patent/LT98188A/xx
Publication of LT4621B publication Critical patent/LT4621B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LT98-188A 1996-06-20 1998-12-18 Nazalinis desmopresino įvedimas LT4621B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/667,047 US5763398A (en) 1996-06-20 1996-06-20 Nasal administration of desmopressin

Publications (2)

Publication Number Publication Date
LT98188A LT98188A (en) 1999-11-25
LT4621B true LT4621B (lt) 2000-02-25

Family

ID=24676595

Family Applications (1)

Application Number Title Priority Date Filing Date
LT98-188A LT4621B (lt) 1996-06-20 1998-12-18 Nazalinis desmopresino įvedimas

Country Status (24)

Country Link
US (1) US5763398A (xx)
EP (1) EP0921786A1 (xx)
JP (1) JP2000502358A (xx)
KR (1) KR20000016781A (xx)
CN (1) CN1233952A (xx)
AU (1) AU707527B2 (xx)
BR (1) BR9700797A (xx)
CA (1) CA2258552A1 (xx)
CZ (1) CZ420198A3 (xx)
EE (1) EE9800453A (xx)
HU (1) HUP9903541A3 (xx)
IL (1) IL127572A (xx)
LT (1) LT4621B (xx)
LV (1) LV12230B (xx)
NO (1) NO985936L (xx)
NZ (1) NZ333124A (xx)
PL (1) PL330902A1 (xx)
RO (1) RO120170B1 (xx)
RU (1) RU2173559C2 (xx)
SI (1) SI9720040A (xx)
SK (1) SK176998A3 (xx)
TR (1) TR199802596T2 (xx)
UA (1) UA49888C2 (xx)
WO (1) WO1997048379A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
EP1121935B1 (en) * 2000-02-04 2008-08-13 Patents Exploitation Company B.V. Pharmaceutical composition containing a small or medium size peptide
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
EP1530967B1 (en) * 2003-11-13 2006-05-03 Ferring B.V. Blister pack and solid dosage form comprising desmopressin
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
AU2008283929B2 (en) 2007-08-06 2013-10-10 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
ES2319054B1 (es) * 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
ES2596435T3 (es) * 2008-05-21 2017-01-09 Ferring B.V. Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nicturia
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
AU2009293019A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care Inc. Solute concentration measurement device and related methods
AU2010260211B2 (en) 2008-12-22 2016-04-21 Acerus Pharmaceuticals USA, LLC Safe desmopressin administration
DK2381923T4 (da) * 2008-12-22 2023-09-11 Acerus Pharmaceuticals Usa Llc Intranasal administration af desmopressin
US20110152770A1 (en) 2009-07-30 2011-06-23 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
FR2954774B1 (fr) * 2009-10-30 2012-01-06 Michelin Soc Tech Methode de preparation d'un melange maitre de caoutchouc naturel et de silice
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
RU2605311C1 (ru) * 2015-07-14 2016-12-20 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Способ лечения болевого синдрома у больных с дегенеративно-дистрофическими заболеваниями позвоночника

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
HU221617B1 (hu) * 1993-06-29 2002-12-28 Ferring B.V. Vizes készítmény dezmopresszin nazális adagolására
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
F. MOREN: "Aerosols in Medicine", pages: 346

Also Published As

Publication number Publication date
NZ333124A (en) 1999-05-28
CN1233952A (zh) 1999-11-03
HUP9903541A2 (hu) 2000-04-28
KR20000016781A (ko) 2000-03-25
BR9700797A (pt) 1998-10-06
SI9720040A (sl) 1999-08-31
NO985936D0 (no) 1998-12-17
AU707527B2 (en) 1999-07-15
IL127572A0 (en) 1999-10-28
CA2258552A1 (en) 1997-12-24
AU3280297A (en) 1998-01-07
US5763398A (en) 1998-06-09
LV12230A (lv) 1999-03-20
IL127572A (en) 2003-04-10
LV12230B (en) 1999-06-20
RO120170B1 (ro) 2005-10-28
PL330902A1 (en) 1999-06-07
EP0921786A1 (en) 1999-06-16
JP2000502358A (ja) 2000-02-29
NO985936L (no) 1999-02-16
LT98188A (en) 1999-11-25
TR199802596T2 (xx) 1999-03-22
SK176998A3 (en) 1999-05-07
EE9800453A (et) 1999-08-16
WO1997048379A1 (en) 1997-12-24
CZ420198A3 (cs) 1999-04-14
RU2173559C2 (ru) 2001-09-20
UA49888C2 (uk) 2002-10-15
HUP9903541A3 (en) 2000-10-30

Similar Documents

Publication Publication Date Title
LT4621B (lt) Nazalinis desmopresino įvedimas
CA2166296C (en) Stabilized pharmaceutical peptide compositions
US5498598A (en) Composition for nasal administration of desmopressin
US5902789A (en) Nasal administration of drugs
US5993781A (en) Fluticasone propionate nebulizable formulations
KR100910888B1 (ko) 에어로졸화 이송을 위한 적절한 토브라마이싱의 조성물
WO1999001135A1 (en) Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
JPH02262526A (ja) カルシトニン組成物およびその用途
NZ231245A (en) Pharmaceutical compositions containing cromoglycic acid and salbutamol
US6967017B1 (en) Formulations of steroid solutions for inhalatory administration
JPH0354647B2 (xx)
MXPA97000440A (en) Pharmaceutical composition nasod administrable monodosis and method of application of such composic
AU2004235732A1 (en) Oral spray to reduce cold symptoms and duration of same
MXPA99011299A (en) Pharmaceutical compositions containing eletriptan hemisulphate and caffeine

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20050610